Sort
141,003 grants matching “cytokine”
Defining Vascular Functions of Proteoglycans through Chemical Biology Approaches
$872,000Kuberan Balagurunathan · Virginia Commonwealth University · P01 · FY2011 · HL
Pilot Project Core
$871,994Chandan Guha · Albert Einstein College Of Medicine · U19 · FY2013 · AI
Mesenchymal stem cell enhancement of organ allograft repair and long term surviva
$871,951Amelia M. Bartholomew · University Of Miami School Of Medicine · P01 · FY2012 · AI
Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization - Service Core
$871,800Peter Skene · Seattle Children'S Hospital · U19 · FY2024 · AI
Novel Adjuvant Discovery in Vaccine Therapy
$871,728Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · AI
SOUTHERN AFRICA-NEW YORK HIV VACCINE TRIALS UNIT
$871,348Medical Research Council Of South Africa · U01 · FY2004 · AI
Novel Concepts for the Eradication of HIV
$871,184Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2013 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2022 · DA
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$871,147Pietro P Sanna · Scripps Research Institute, The · R01 · FY2021 · DA
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$871,073John H Sampson · Duke University · U01 · FY2019 · NS
Project 1: Development of Nucleoside-Modified mRNAs Encoding Sequential HIV-1 Envelopes for Initiation of V3-glycan Neutralizing Antibody Lineages
$871,042Barton F Haynes · Duke University · U19 · FY2020 · AI
SCOR on the Pathogenesis of Scleroderma
$870,959University Of Tennessee Health Sci Ctr · P50 · FY2003 · AR
NF-kappaB in pathogenesis and therapy of head and neck cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
Genomics and Proteomics of Head and Neck Cancer
$870,939Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZIA · FY2013 · DC
BLOCKING INFECTIOUS ENTRY OF STD PATHOGENS
$870,914Johns Hopkins University · P01 · FY2003 · AI
Immunobiology and therapy of oral mucosal and salivary gland chronic graft-versus-host disease
$870,744Jacqueline Mays · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE
Once Bitten: Acquisition of Malaria Adaptive Immunity (OBAMA - Immunity)
$870,556Wendy Prudhommeomeara · Duke University · R01 · FY2023 · AI
Prevention of Lung Transplant Injury with Adenosine 2A Receptor Agonis
$870,551Christine L Lau · University Of Maryland Baltimore · R01 · FY2020 · HL
Project 1 Immunometabolic Determinants of Susceptibility
$870,530Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
Function of granulysin
$870,505Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Characterization And Functional Significance Of P450 Arachidonate Epoxygenases
$870,318Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Mechanisms of mucosal protection induced by attenuated SIV
$870,309R. Paul Johnson · Harvard Medical School · P01 · FY2008 · AI
Phase 1/2 Clinical Trial to assess the safety and preliminary efficacy of Lipoxin Analog BLXA4-MEOral Rinse for the Treatment of Gingivitis
$870,304Thomas E Van Dyke · Ada Forsyth Institute, Inc. · U01 · FY2016 · DE
Molecular Therapy Core Centers
$870,218Arthur Dusty Miller · University Of Washington · P30 · FY2007 · DK
Molecular Therapy Core Centers
$870,218Arthur Dusty Miller · University Of Washington · P30 · FY2008 · DK